Girardi, E
Deferasirox selectively induces cell death in the clinically relevant population of leukemic CD34+CD38- cells through iron chelation, induction of ROS, and inhibition of HIF1 expression
By technically positioning the product as a research chemical rather than a drug intended for human use, vendors sidestep the FDA oversight that governs pharmaceutical products
10.1038/s41556-018-0178-0 Summary Keywords ferroptosis, programmed cell death, dermatology, cancer, inflammation Citation Liu L, Lian N, Shi L, Hao Z and Chen K (2023) Ferroptosis: Mechanism and connections with cutaneous diseases
Heres What the Science Says Discover the science-backed truth about supplements to slow aging
If you are considering switching between medications, understanding injection technique at each site gives you flexibility